Marie Skłodowska-Curie Actions

The Marie Skłodowska-Curie Actions are a European Commission Funding Programme that supports researchers at all stages of their careers, across all research disciplines and in all employment sectors: Postdoctoral fellowships, doctoral networks and staff exchanges as well at the COFUND option, for institutes to run their own calls. The opening and closing dates for these calls are similar each year.

MSCA fund excellent and innovative research training as well as attractive career development and knowledge-exchange opportunities through cross-border and cross-sector mobility of researchers, to better prepare them for current and future societal challenges. This funding aims to reinforce cooperation between academia and all types of non-academic organisations (companies, hospitals, public bodies etc.) in terms of research training, career development and knowledge transfer.

The Irish Marie Skłodowska-Curie Office provide excellent resources to support researchers, and their YouTube channel provides an excellent webinar series and case studies of wining projects. Their website also supplies an updated series of handbooks every year.  

MSCA CURRENT (ALL TYPES)

MedTrain+ (COFUND) (2022-2026) aims to develop 50 postdoctoral fellowships to become future leaders in medical device research

flIMAGIN3D (Doctoral Network) (2023-2026) aims to train doctoral researchers to advance the acquisition of FLIM (Fluorescence Lifetime Imaging Microscopy) data and the analysis pipeline for a wide range of (bio)medical, chemical and biophysical applications

HaPpY (Doctoral Network) (2021-2025) Comorbidity of cHronic Pain and mood disorders: breaking the vicious cYcle (2021-2025) aims ensure that discoveries in fundamental research can swiftly move toward clinical settings@HaPpYejd2021

ADMIRE (COFUND) Advanced Materials Research Postdoctoral Fellowship Programme (2020-2025) is training the next generation of research leaders in Europe in advanced materials science by funding 12 two-year incoming fellowships in Ireland @AdmireMsca

DEVELOPMED (COFUND) (2021-2025) is developing the Next Generation of Research Leaders in Precision Oncology by providing training for 12 three-year fellowships

BioBased Value Circle (Doctoral Network) (2020-2024) Training industrial doctorates in the transition towards bio-based value circles, BioBased ValueCircle  in 12 interlinked doctoral projects, providing them valuable insight into the industry and academic research environments LinkedIN

CareerFit PLUS (COFUND) (2019-2025) is the successor to the Career-FIT programme, offering a maturity of approach with key learnings from engagement of Enterprise Ireland, the host organisations and past Fellows

NatureETNEuropean Training Network(2020-2024) Nucleic Acids for Future Gene Editing, Immunotherapy and Epigenetic Sequence Modification, aims to train 15 Early Stage Researchers (ESRs) to help fulfil the need for highly qualified experts in the biotechnology and biopharmaceutical industries

LOGIC LAB (ITN) (2018-2023) Molecular logic lab-on-a-vesicle for intracellular diagnostics. LOGIC LAB aims to develop and characterise innovative molecular logic gates that can be applied as advanced diagnostic tools for parallel analyte sensing in live mammalian cells @LogicLab_ITN

LectiNet (2021-2024) is an MSCA global fellowship study the engagement of antigens on transmembrane C-type lectin receptors with a secondment at MIT

SilVerDBS (2022-2023) aims to design a novel algorithm for closed-loop deep brain stimulation DBS  and to demonstrate its superior efficiency in terms of symptom reduction, longer battery life and fewer treatment-induced side effects for neurological disorders

Pulmonary Fibrosis (2022-2025) will leverage the promising effect of Galectin-3 in slowing idiopathic pulmonary fibrosis progression using the bleomycin-induced preclinical model

SYNMAT FOR ORGANOIDS (2022-2025) aims to develop the next generation of human intestinal organoids (HIOs) using microfluidics encapsulation in synthetic niches

MINECHPS-SCI (2023-2025) proposes to develop a combinatorial approach for enhancing regeneration in the spinal cord after injury

MSCA COMPLETED (ALL TYPES)

Tendon Therapy Train (ITN) (2016-2020) Engineering in vitro microenvironments for translation of cell-based therapies for tendon repair. Tendon Therapy Train was training programme for human and equine tendon repair @Tendon_Therapy

BrainMatTrain (ITN) (2016-2020) Development of Biomaterial-based Delivery Systems for Parkinson’s disease - an Integrated Pan-European Approach, BrainMatTrain focused on a comprehensive understanding of Parkinson’s disease, from basics to translation, fully supported by eight full partners (four research institutions, two hospitals, two SMEs) and one partner organisation (SME specialist in device design) @BrainMatTrain Draw My Parkinson’s

TRAIN-ERS (MSCA ITN) (2015-2019) Endoplasmic Reticulum Stress in Health and Disease. The TRAIN-ERS network provided early-stage researchers (ESRs) with high quality scientific and complementary skills training aimed at understanding the Endoplasmic Reticulum stress response

MedTrain (COFUND) (2016-2021) offered 31 prestigious two-year postdoctoral fellowships for incoming mobility to eligible Experienced Researchers in the area of Medical Device Research and Development across two calls @MedTrainFellows

AngioMatTrain (ITN) (2013-2017) Development of Biomaterial-based Delivery Systems for Ischemic Conditions. This ITN trained 12 ESRs and 3 Experienced Researchers scientists in: tissue engineering, materials science, chemistry, functionalisation, cell biology, nanotechnology, bio-analytical techniques, animal models and prototype design

EPICSTENT (FP7 IAPP) (2013-2017) Antibody-functionalised cardiovascular stents for improved biocompatibility and reduced restenosis; established inter-national partnerships for knowledge transfer in biomaterials engineering for 16 ESRs

SOLAR2CHEM (ITN) (2020-2024) SOLAR2CHEM trains 15 ESRs in state-of-the-art concepts and techniques on physical sciences to research on hybrid devices for producing solar chemicals and manufacturing environmental footprints @solar2chem

PREMUROSA (ITN) (2020-2024) Precision medicine for muscoloskeletal regeneration, prosthetics and active ageing trains 13 ESRs in the value chain to boost the necessary innovations to achieve precision principles in developing innovative devices and optimised clinical applications @ThePremurosa

NEUcrest (ITN) (2019-2024) Training European Experts in Multiscale Studies of Neural Crest Development and Disorders: from Patient to Model Systems and Back trained ESRs in genetic, molecular and environmental regulation of NC tissue in human health. @INeucrest

PMSMATTRAIN(ITN) (2019-2023) Novel Biomaterial-based Device for Treating Progressive MS- - An Integrated Pan- European Approach. PMSMatTrain focused on the progressive (late degenerative) phase of multiple sclerosis from basics to translation @PMSMatTrain

ImplantSens (ITN) (2019-2023) Mass-transfer independent long-term implantable biosensor, ImplantSens trained scientists in biosensors to advance enzymatic glucose sensors and combine nanomaterials towards improved sensor biocompatibility and accuracy @ImplantSens

BioImplant ITN (ITN) (2019-2023) is developing Improved Bioresorbable Materials for Orthopaedic and Vascular Implant Applications @BioimplantITN

RenalToolBox (ITN) (2018-2023) novel tools to assess the safety/efficacy of cell-based regenerative medicine therapies, focusing on kidney disease. RenalToolBox is developing medical devices and imaging technologies to expedite the translation of cell-based regenerative therapies @renaltoolbox

NanoCarb (ITN) (2018-2023) develops novel and characterised nanomaterials with synthetic and native N-glycans for therapeutics and guide development of new drug delivery applications@nanocarbproject

Marie Skłodowska-Curie FELLOWSHIPS/STAFF EXCHANGES (PAST)

CÚRAM Investigators and Researchers were involved in the following Individual Marie SkłodowskaCurie Fellowships/Staff Exchanges.

3D-NEONET (2017-2022) 3D-NEONET improved treatments for cancer/ ocular disease by enhancing drug discovery-development and delivery to targeted tissues. @3dneonet

Multiple Sclerosis (2018-2020) Developed a Functionalised Biomaterial Scaffold to Treat Multiple Sclerosis

SKIN SUBSTITUTE (2018-2020) Development of hybrid artificial skin substitute for chronic diabetic wounds

SUGARSmart (2018-2020)  Smart design of recombinant antibody fragments specific for carbohydrate molecules

EsterPep (2017-2019) Polyester/Polypeptide hybrid biomaterials for biomedical scaffolds

PoreSelect (2016-2018) Macroporous Polymer Monoliths as a Low-Cost Bioanalytical Platform for Biopharmaceutical Glycoprotein

NanoCap (2016-2018) Sustainable Polypeptide Nanoparticle Platform for Drug Delivery

REAP (2015-2017) Real-time Diagnostics for Enabling Advanced Laser-based Roll to Roll Materials Processing

MicroPod (2015-2017) MICROPOrous Devices for next-generation therapeutic delivery